BlackRock Investment Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

BlackRock Investment Management’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.48M	Sell	26,014 -142	-0.5%	-$8.59K	﹤0.01%	2427
2016 Q3	$1.63M	Buy	26,156 +123	+0.5%	+$8.7K	﹤0.01%	2319
2016 Q2	$1.47M	Buy	26,033 +20,385	+361%	+$1.24M	﹤0.01%	2355
2016 Q1	$362K	Buy	5,648 +107	+2%	+$8.65K	﹤0.01%	3017
2015 Q4	$780K	Buy	5,541 +31	+0.6%	+$4.21K	﹤0.01%	2762
2015 Q3	$534K	Sell	5,510 -1,477	-21%	-$176K	﹤0.01%	3000
2015 Q2	$1.06M	Buy	+6,987	New	+$1.15M	﹤0.01%	2725

Other funds holding KDNY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Investment Management's KDNY Position: Q4 2016 in Review

BlackRock Investment Management reduced its Chinook Therapeutics, Inc. Common Stock (KDNY) stake by 0.54% in Q4 2016, selling an estimated $8.59K and leaving 26,014 shares worth $1.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2427.

BlackRock Investment Management first reported a position in KDNY in Q2 2015 and has held it in 7 quarters since. The position peaked at $1.63M in Q3 2016. 87 funds tracked by Wall St. Rank hold KDNY as of Q4 2016.

BlackRock Investment Management held 26,014 shares of Chinook Therapeutics, Inc. Common Stock worth $1.48M as of Q4 2016.
BlackRock Investment Management sold 142 Chinook Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $8.59K.
Chinook Therapeutics, Inc. Common Stock made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2427 holding.
BlackRock Investment Management first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and has held it in 7 quarters since.
BlackRock Investment Management's Chinook Therapeutics, Inc. Common Stock position peaked at $1.63M in Q3 2016.
87 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.